275 related articles for article (PubMed ID: 21861747)
1. Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery.
Schwarzmaier-D'Assie A; Nyolczas N; Hemetsberger R; Strehblow C; Matiasek J; Farhan S; Petrasi Z; Huber K; Wojta J; Glogar D; Plass C; Gyöngyösi M; Karnik R
J Endovasc Ther; 2011 Aug; 18(4):547-58. PubMed ID: 21861747
[TBL] [Abstract][Full Text] [Related]
2. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.
Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Naka KK; Fotiadis DI; Michalis LK
JACC Cardiovasc Interv; 2010 Nov; 3(11):1181-9. PubMed ID: 21087755
[TBL] [Abstract][Full Text] [Related]
3. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.
Gandini R; Del Giudice C; Da Ros V; Sallustio F; Altobelli S; D'Onofrio A; Abrignani S; Vasili E; Stanzione P; Simonetti G
J Endovasc Ther; 2014 Oct; 21(5):671-7. PubMed ID: 25290795
[TBL] [Abstract][Full Text] [Related]
6. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
[TBL] [Abstract][Full Text] [Related]
7. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
Hemetsberger R; Farhan S; Strehblow C; Sperker W; Pavo I; Petrasi Z; Hemetsberger H; Posa A; Huber K; Glogar D; Gyöngyösi M
Coron Artery Dis; 2008 Dec; 19(8):635-43. PubMed ID: 19005299
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts.
Wong G; Li JM; Hendricks G; Eslami MH; Rohrer MJ; Cutler BS
J Vasc Surg; 2008 Mar; 47(3):608-15. PubMed ID: 18295112
[TBL] [Abstract][Full Text] [Related]
9. Local paclitaxel delivery after coronary stenting in an experimental animal model.
Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
[TBL] [Abstract][Full Text] [Related]
10. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
11. Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model.
Milewski K; Zurakowski A; Pajak J; Liszka L; Debinski M; Buszman PP; Samra MA; Dominek P; Aboodi MS; Kaluza GL; Buszman P
Cardiovasc Revasc Med; 2011; 12(2):82-9. PubMed ID: 21421185
[TBL] [Abstract][Full Text] [Related]
12. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
[TBL] [Abstract][Full Text] [Related]
13. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
[TBL] [Abstract][Full Text] [Related]
14. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
[TBL] [Abstract][Full Text] [Related]
15. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
[TBL] [Abstract][Full Text] [Related]
16. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
[TBL] [Abstract][Full Text] [Related]
17. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
Aoki J; Mintz GS; Weissman NJ; Mann JT; Cannon L; Greenberg J; Grube E; Masud AR; Koglin J; Mandinov L; Stone GW
JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294
[TBL] [Abstract][Full Text] [Related]
18. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF
JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706
[TBL] [Abstract][Full Text] [Related]
19. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
Tanabe K; Serruys PW; Degertekin M; Guagliumi G; Grube E; Chan C; Munzel T; Belardi J; Ruzyllo W; Bilodeau L; Kelbaek H; Ormiston J; Dawkins K; Roy L; Strauss BH; Disco C; Koglin J; Russell ME; Colombo A;
Circulation; 2004 Jan; 109(2):196-200. PubMed ID: 14691036
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
